Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M30.2Revenue (TTM) $M0.2Net Margin (%)-3,476.5Altman Z-Score11.8
Enterprise Value $M0.7EPS (TTM) $-0.5Operating Margin %-5,383.3Piotroski F-Score4
P/E(ttm)--Beneish M-Score-3.8Pre-tax Margin (%)-3,468.5Higher ROA y-yN
Price/Book0.910-y EBITDA Growth Rate %-23.8Quick Ratio27.1Cash flow > EarningsY
Price/Sales--5-y EBITDA Growth Rate %-24.1Current Ratio27.1Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-26.5Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-27.8Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M17.2ROIC % (ttm)-979.4Gross Margin Increase y-yN

Gurus Latest Trades with NVGN

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
Current Price Change from Average Comment Current Shares
NVGNRonald Muhlenkamp 2013-03-31 Sold Out -0.03%$1.84 - $9.05
$ 1.76-54%Sold Out0
NVGNRonald Muhlenkamp 2012-12-31 Reduce-0.01%$1.5 - $10.24
$ 1.76-65%Reduce -49.15%18,184
NVGNRonald Muhlenkamp 2012-06-30 Buy 0.02%$1.95 - $2.5
$ 1.76-22%New holding35,757
NVGNRonald Muhlenkamp 2011-12-31 Reduce-0.01%$0.66 - $1.18
$ 1.76107%Reduce -32.42%35,758
NVGNRonald Muhlenkamp 2011-09-30 Add$0.92 - $2.14
$ 1.7632%Add 4.70%52,915
NVGNRonald Muhlenkamp 2011-06-30 Reduce$1.32 - $2.95
$ 1.76-14%Reduce -1.45%50,542
NVGNRonald Muhlenkamp 2011-03-31 Add$0.84 - $3.57
$ 1.7620%Add 1.88%51,287
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

NVGN is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!

NVGN: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Quarterly/Annual Reports about NVGN:

    News about NVGN:

    Articles On GuruFocus.com
    Novogen (NVGN) Promising Data in Brain Cancer; eFuture Information Technology (EFUT) and NeoPhotonic Mar 04 2015 

    More From Other Websites
    Issue of unlisted options under ESOP New Oct 20 2016
    Annual Report for the year ended 30 June 2016 New Oct 20 2016
    Notice of Annual General Meeting New Oct 20 2016
    Conversion of Convertible Notes Sep 13 2016
    Novogen secures key US drug study approval Sep 12 2016
    US FDA Approves Investigational New Drug (IND) Application for Cantrixil(TM) (TRX-E-002-1) in... Sep 11 2016
    Resignation/appointment of Company Secretary Sep 11 2016
    FDA approves IND application for Cantrixil Sep 11 2016
    Novogen Announces FDA Approves IND Application for Cantrixil in Ovarian Cancer Sep 11 2016
    Novogen appoints Scientific Advisory Board to guide development of oncology pipeline Sep 04 2016
    Appendix 4E and Full Year Statutory Accounts Aug 30 2016
    Novogen appoints Key Management Personnel to drive transition to a development-focused organisation Aug 28 2016
    Novogen Submits IND Application to the US FDA for Cantrixil in Ovarian Cancer Aug 14 2016
    Novogen Submits Investigational New Drug (IND) Application to the US FDA For Cantrixil(TM) in... Aug 11 2016
    Novogen Patent Covering Anisina(TM) Has Proceeded to Grant Jun 13 2016
    Novogen Patent Covering Anisina Has Proceeded to Grant Jun 13 2016
    Edison Investment Research Report maintains valuation as Novogen resumes 100% ownership of Cantrixil May 09 2016
    Novogen Provides Update On Development Of Cantrixil May 01 2016
    Novogen Provides Update on Development of Cantrixil May 01 2016
    Cantrixil (TRXE-002-1) Abstract (AACR Annual Meeting 2016) Apr 17 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)